These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 28837144)

  • 1. Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer.
    Chen DL; Chen LZ; Lu YX; Zhang DS; Zeng ZL; Pan ZZ; Huang P; Wang FH; Li YH; Ju HQ; Xu RH
    Cell Death Dis; 2017 Aug; 8(8):e3011. PubMed ID: 28837144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.
    Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH
    Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 4. Long Noncoding RNA XIST Regulates miR-137-EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer.
    Liu X; Cui L; Hua D
    Oncol Res; 2018 Dec; 27(1):99-106. PubMed ID: 29495975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
    Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
    Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
    Chen DL; Lu YX; Zhang JX; Wei XL; Wang F; Zeng ZL; Pan ZZ; Yuan YF; Wang FH; Pelicano H; Chiao PJ; Huang P; Xie D; Li YH; Ju HQ; Xu RH
    Theranostics; 2017; 7(19):4836-4849. PubMed ID: 29187907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of LncRNA XIST/ miR-101-3p/ZEB1 axis in EMT associated with silicosis.
    Li C; Xia J; Yao W; Yang G; Tian Y; Qi Y; Hao C
    Toxicol Lett; 2022 May; 360():11-19. PubMed ID: 35271943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2.
    Liu A; Liu L; Lu H
    J Cell Physiol; 2019 Aug; 234(8):13747-13761. PubMed ID: 30656681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1/2 expression.
    Liu L; Jiang H; Pan H; Zhu X
    J Int Med Res; 2021 May; 49(5):3000605211016211. PubMed ID: 34018840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p.
    Yu X; Wang D; Wang X; Sun S; Zhang Y; Wang S; Miao R; Xu X; Qu X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):32. PubMed ID: 30678736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101.
    Cheng Y; Chang Q; Zheng B; Xu J; Li H; Wang R
    Eur J Pharmacol; 2019 Jan; 843():210-216. PubMed ID: 30472203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
    Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-coding RNA X-Inactive Specific Transcript Promotes Esophageal Squamous Cell Carcinoma Progression via the MicroRNA 34a/Zinc Finger E-box-Binding Homeobox 1 Pathway.
    Guo B; He M; Ma M; Tian Z; Jin J; Tian G
    Dig Dis Sci; 2024 Apr; 69(4):1169-1181. PubMed ID: 38366093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H
    Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.